Skip to content
LexBuild

National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect

---
identifier: "/us/fr/04-24391"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect"
title_number: 0
title_name: "Federal Register"
section_number: "04-24391"
section_name: "National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect"
positive_law: false
currency: "2004-11-02"
last_updated: "2004-11-02"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "04-24391"
document_type: "notice"
publication_date: "2004-11-02"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "69 FR 63546"
fr_volume: 69
---

#  National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC)  announces the following Federal advisory committee meeting.

**NAME:**

National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect (NTFFASFAE).

**TIMES AND DATES:**

9 a.m.-4:30 p.m., December 6, 2004; 9 a.m.-12 noon, December 7, 2004.

**PLACE:**

Westin Buckhead Atlanta Hotel, 3391 Peachtree Road, NE., 30326, telephone (404) 365-0065, fax (404) 365-8787.

**STATUS:**

Open to the public, limited only by the space available. The meeting room accommodates approximately 65 people.

**PURPOSE:**

The Secretary is authorized by the Public Health Service Act, Section 399G, (42 U.S.C. S 280f, as added by Public Law 105-392) to establish a National Task Force on Fetal Alcohol Syndrome and Fetal Alcohol Effect to: (1) Foster coordination among all governmental agencies, academic bodies and community groups that conduct or support Fetal Alcohol Syndrome (FAS) and Fetal Alcohol Effect (FAE) research, programs and surveillance; and(2) to otherwise meet the general needs of populations actually or potentially impacted by FAS and FAE.

**MATTERS TO BE DISCUSSED:**

Agenda items include: An overview of effective strategies to reduce the risk of problem drinking and alcohol-exposed pregnancies; what is needed to implement effective programs in the service delivery system; alcohol advertising and adolescent girls; and a discussion of issues presented. Additional agenda items include: Prevention and Post-Exposure working group sessions; updates from Task Force members on current initiatives; an update on activities from the Interagency Coordinating Committee on Fetal Alcohol Syndrome, the CDC and other Federal agencies; future topics, and scheduling the next meeting.

Agenda items are subject to change as priorities dictate.

**FOR FURTHER INFORMATION CONTACT:**

R. Louise Floyd,DSN, RN, Designated Federal Official, National Center on Birth Defects and Developmental Disabilities, CDC, 1600 Clifton Road, NE., (E-86), Atlanta, Georgia 30333, telephone (404) 498-3923, fax (404) 498-3550.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities for both the CDC and ATSDR.

Dated: October 27, 2004.

B. Kathy Skipper,

Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.